Concepedia

Sharron A. Rhodes

SA

3

Publications

163

Citations

3

H-Index

2000

Active since

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Sharron A. Rhodes is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

MedicinePharmacologyDrug DiscoveryPharmacotherapyPhysiologyBiochemistryNeuroscienceEndocrinologyNeurochemistryDrug Development

Publications per year

2000–2006

3

Publications

3

GW627368X ((<i>N</i>‐{2‐[4‐(4,9‐diethoxy‐1‐oxo‐1,3‐dihydro‐2<i>H</i>‐benzo[<i>f</i>]isoindol‐2‐yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP<sub>4</sub> receptor antagonist

Richard J. Wilson, Gerard M.P. Giblin, Susan Roomans et al. · British Journal of Pharmacology · 2006 · 78 citations · Full text

Molecular Pharmacology, Antagonist Affinity, Selective Competitive Antagonist +13

Functional pharmacology of human prostanoid EP2 and EP4 receptors

Richard J. Wilson, Sharron A. Rhodes, Richard L. Wood et al. · European Journal of Pharmacology · 2004 · 60 citations

Medicine, Receptor (Biochemistry), Pharmacotherapy +2

Use of a Dual Firefly and Renilla Luciferase Reporter Gene Assay to Simultaneously Determine Drug Selectivity at Human Corticotrophin Releasing Hormone 1 and 2 Receptors

Sarah J. Parsons, Sharron A. Rhodes, Helen E. Connor et al. · Analytical Biochemistry · 2000 · 25 citations

Medicine, Physiology, Neuroendocrine Mechanism +7

Rows per page

1–3 of 3